| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/23/2013 | CN102525909B Method for preparing penehyclidine hydrochloride injection |
| 01/23/2013 | CN102440958B Ibuprofen sodium liposome solid preparation and preparation method thereof |
| 01/23/2013 | CN102429851B Blood-circulation-promoting, weight-reducing and fat-lowering bath vinegar combining vinegar and traditional Chinese medicines and preparation method thereof |
| 01/23/2013 | CN102406606B Solid quetiapine fumarate liposome preparation |
| 01/23/2013 | CN102397265B Method for preparing sinomenine hydrochloride membrane-controlled enteric controlled-release tablet |
| 01/23/2013 | CN102397253B Clopidogrel bisulfate liposome solid preparation |
| 01/23/2013 | CN102397249B Cefetamet pivoxil hydrochloride liposome solid preparation |
| 01/23/2013 | CN102335190B Reductively degradable mercaptopurine nanometer micellar prodrug with controllable drug release and application thereof |
| 01/23/2013 | CN102327265B Amlodipine and olmesartan medoxomil pharmaceutical composition and preparation method thereof |
| 01/23/2013 | CN102327238B Levocarnitine composition for injection and preparation method of levocarnitine composition |
| 01/23/2013 | CN102327221B Cefadroxil liposome solid preparation |
| 01/23/2013 | CN102319215B Vecuronium bromide liposome injection |
| 01/23/2013 | CN102309452B Fluvastatin sodium liposome solid preparation |
| 01/23/2013 | CN102293752B Preparation method of chitosan-carried capsaicin microsphere as well as microsphere and application of microsphere in weight reduction and sugar reduction |
| 01/23/2013 | CN102274181B Docetaxel lipid microsphere injection and preparation method thereof |
| 01/23/2013 | CN102228557B Chinese herbal medicine for treating paranasal sinusitis |
| 01/23/2013 | CN102228483B Freeze-dried preparation of xanthone anti-tumour medicine and preparation method thereof |
| 01/23/2013 | CN102225198B Anti-tumour medicine composition and preparation method and application thereof |
| 01/23/2013 | CN102210645B Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof |
| 01/23/2013 | CN102198087B Preservative-free ophthalmic in-situ gelling agent and preparation method thereof |
| 01/23/2013 | CN102188503B Preparation method of total glucosides from Paeonia lactiflora Pall., and Paeonia lactiflora Pall. total glucoside preparation and use thereof |
| 01/23/2013 | CN102188371B Ciclesonide nanoparticle aqueous solution and preparation method thereof |
| 01/23/2013 | CN102160855B Dex-ibuprofen sustained release tablets and preparation method thereof |
| 01/23/2013 | CN102138895B Eyedrops containing fasudil hydrochloride and preparation method thereof |
| 01/23/2013 | CN102119926B Valsartan self-emulsifying medicament transfer system and preparation method thereof |
| 01/23/2013 | CN102112120B Composition and method for treatment of MRSA |
| 01/23/2013 | CN102093319B 3-aryl-4-(2-glycosyl/amino ethyoxyl)-2(5H)-furanone compound, preparation method thereof and application thereof |
| 01/23/2013 | CN102091051B Allopurinol dual-release preparation and preparation method thereof |
| 01/23/2013 | CN102078310B Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 01/23/2013 | CN102076340B Transdermal patch containing fentanyl or salt thereof |
| 01/23/2013 | CN102058678B Medicine or health-care food composition for treating fatty liver |
| 01/23/2013 | CN102030791B Four tiacumicin compounds as well as preparation methods and applications thereof in preparing antimicrobial agents |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN102018713B Medicinal composition |
| 01/23/2013 | CN102014898B Tetrazole compounds for reducing uric acid |
| 01/23/2013 | CN102010396B Cytospolides with anti-tumor and antibacterial activity |
| 01/23/2013 | CN101987866B Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof |
| 01/23/2013 | CN101987126B Medical burn antipyretic gauze and preparation thereof |
| 01/23/2013 | CN101973922B Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor |
| 01/23/2013 | CN101952290B Sulfonyl-substituted carbapenem compounds |
| 01/23/2013 | CN101914117B Dichloroacetoxyl-containing platinum (II) anticancer coordination compound |
| 01/23/2013 | CN101910127B (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 01/23/2013 | CN101909608B A slow-release formulation based on an association of glycogen and alginate |
| 01/23/2013 | CN101904815B Ibuprofen microemulsion preparation and preparation method |
| 01/23/2013 | CN101855227B Heterocyclic derivatives |
| 01/23/2013 | CN101808628B Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient |
| 01/23/2013 | CN101801382B Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 01/23/2013 | CN101791309B Oral solid preparation containing clopidogrel hydrogen sulfate |
| 01/23/2013 | CN101766561B Antibacterial gel and preparation method thereof |
| 01/23/2013 | CN101759720B Acyclic nucleoside phosphonate compounds or pharmaceutically acceptable salts thereof, preparation method, application, intermediate compounds thereof, and medicinal composition containing same |
| 01/23/2013 | CN101757001B Compound slow-release preparation of benorilate, pseudoephedrine and chlorphenamine |
| 01/23/2013 | CN101742992B The application of 5-methyl-1,3-benzenediol or derivatives thereof in the preparation of medicines and functional foods for treatment or prevention of depression |
| 01/23/2013 | CN101742989B Microspheres having core/shell structure |
| 01/23/2013 | CN101721431B Compound nano pearl starch ball and production process thereof |
| 01/23/2013 | CN101703690B Medicament for treating metrorrhagia and metrostaxis, hematemesis, hematochezia and traumatic hemorrhage and preparation method thereof |
| 01/23/2013 | CN101687049B Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 01/23/2013 | CN101657192B Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/23/2013 | CN101654456B Water-soluble derivants containing 10-hydroxycamptothecine and preparation method thereof |
| 01/23/2013 | CN101647779B Novel almoxicillin sodium and clavulanate potassium compound powder preparation for injection and technology for preparing same |
| 01/23/2013 | CN101641112B A novel combination of epimedium-derived-flavonoids-fractions for prevention of steroid-induced osteonecrosis |
| 01/23/2013 | CN101628913B Compound as estrogen-related receptor modulator and application thereof |
| 01/23/2013 | CN101616913B Fused cyclic compounds |
| 01/23/2013 | CN101607907B Substituted benzoic acid derivative and synthesizing method thereof and application thereof |
| 01/23/2013 | CN101595105B 2-substituted 5-membered heterocycles as SCD inhibitors |
| 01/23/2013 | CN101583361B Cytoskeletal active RHO kinase inhibitor compounds, composition and use |
| 01/23/2013 | CN101573357B 吲哚化合物 Indole compound |
| 01/23/2013 | CN101573051B Tasteless nutritional supplement containing free amino acids |
| 01/23/2013 | CN101511370B Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 01/23/2013 | CN101501035B Pyrimidine derivative as P13K inhibitor and use thereof |
| 01/23/2013 | CN101490017B Therapeutic piperazines as pde4 inhibitors |
| 01/23/2013 | CN101486715B Novel oxazine compound and use for preventing platelet aggregation |
| 01/23/2013 | CN101474300B Pharmaceutical composition for reducing blood sugar, blood fat and treating diabetes |
| 01/23/2013 | CN101450915B Cyclohexene substituted benzoic acid derivatives |
| 01/23/2013 | CN101422615B Oridonin polymer micelle administration preparation and preparation method thereof |
| 01/23/2013 | CN101421261B Tetracyclic steroid derivatives useful as progesterone receptor modulators |
| 01/23/2013 | CN101352521B 灰指甲药及其制备方法 Onychomycosis drug and its preparation method |
| 01/23/2013 | CN101336247B Antiviral nucleosides |
| 01/23/2013 | CN101330838B Method for preventing diseases in infants delivered via caesarean section |
| 01/23/2013 | CN101314045B Sulphur butyl ether-beta-cyclodextrin clathrate compound of cinnarizine, formulated product and preparation method thereof |
| 01/23/2013 | CN101248072B 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 01/23/2013 | CN101244044B Entecavir dispersible tablet and preparation thereof |
| 01/23/2013 | CN101213300B Oligonucleotides for RNA interference and biological applications thereof |
| 01/23/2013 | CN101128456B Quinazoline derivatives as tyrosine kinase inhibitors |
| 01/23/2013 | CN101119720B Compositions containing polysaccharides |
| 01/23/2013 | CN101111599B Expression carrier used for treating bacterial infection |
| 01/23/2013 | CN101107015B 乳腺炎用注入剂 Mastitis with implants |
| 01/23/2013 | CN101027034B Composition for oral cavity |
| 01/23/2013 | CN101023962B Western-Chinese medicine compounded preparation for treating gout |
| 01/22/2013 | US8357809 Acyclic IKur inhibitors |
| 01/22/2013 | US8357805 (1R,1′R)-atracurium salts separation process |
| 01/22/2013 | US8357804 Crystal forms of kinase inhibitors |
| 01/22/2013 | US8357794 Exopolysaccharide |
| 01/22/2013 | US8357791 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 01/22/2013 | US8357789 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/22/2013 | US8357785 Method of aralkylation of 4′-hydroxyl group of anthracylins |
| 01/22/2013 | US8357723 Prodrugs containing novel bio-cleavable linkers |
| 01/22/2013 | US8357722 Lipids, lipid complexes and use thereof |
| 01/22/2013 | US8357721 Therapy for diabetic retinopathy |
| 01/22/2013 | US8357720 Treatment or prevention of cancer and precancerous disorders |
| 01/22/2013 | US8357719 Muscle relaxant using negatively charged gold nanoparticles with choline |